CAD 0.07
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 43.93 Thousand CAD | 0.0% |
2022 | - CAD | 0.0% |
2021 | - CAD | 0.0% |
2020 | - CAD | 0.0% |
2019 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 148.1 Thousand CAD | 506.05% |
2024 Q2 | 152.71 Thousand CAD | 3.11% |
2023 Q1 | - CAD | 0.0% |
2023 FY | 43.93 Thousand CAD | 0.0% |
2023 Q4 | 24.43 Thousand CAD | 25.37% |
2023 Q3 | 19.49 Thousand CAD | 0.0% |
2023 Q2 | - CAD | 0.0% |
2022 Q2 | - CAD | 0.0% |
2022 FY | - CAD | 0.0% |
2022 Q1 | - CAD | 0.0% |
2022 Q4 | - CAD | 0.0% |
2022 Q3 | - CAD | 0.0% |
2021 Q4 | - CAD | 0.0% |
2021 FY | - CAD | 0.0% |
2021 Q1 | - CAD | 0.0% |
2021 Q2 | - CAD | 0.0% |
2021 Q3 | - CAD | 0.0% |
2020 FY | - CAD | 0.0% |
2020 Q4 | - CAD | 0.0% |
2020 Q3 | - CAD | 0.0% |
2020 Q2 | - CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | - CAD | -Infinity% |
Asep Medical Holdings Inc | 21.14 Thousand CAD | -107.81% |
BetterLife Pharma Inc. | - CAD | -Infinity% |
BioVaxys Technology Corp. | - CAD | -Infinity% |
ChitogenX Inc. | - CAD | -Infinity% |
Rapid Dose Therapeutics Corp. | 1.02 Million CAD | 95.695% |
Defence Therapeutics Inc. | - CAD | -Infinity% |
Entheon Biomedical Corp. | 250.32 Thousand CAD | 82.45% |
Gemina Laboratories Ltd. | - CAD | -Infinity% |
Lexston Life Sciences Corp. | - CAD | -Infinity% |
Pharmala Biotech Holdings Inc. | 532 Thousand CAD | 91.742% |
Doseology Sciences Inc. | 98.52 Thousand CAD | 55.41% |
MYND Life Sciences Inc. | - CAD | -Infinity% |
Nova Mentis Life Science Corp. | 28.34 Thousand CAD | -54.981% |
PharmaTher Holdings Ltd. | - CAD | -Infinity% |
PreveCeutical Medical Inc. | - CAD | -Infinity% |
Telescope Innovations Corp. | 595.39 Thousand CAD | 92.622% |